Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases.

Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases. Genet Med. 2022 01; 24(1):109-118.

View in: PubMed